tirzepatide sleep apnea study for the Treatment of Obstructive and Obesity Mounjaro Drug Tirzepatide Could Treat

(PubMed) Carr AC, Block G, Lykkesfeldt J

Compared with other CVOTs involving GLP-1RA, participants in the AMPLITUDE-O trial had the longest duration of diabetes (15 years), lowest mean eGFR (72 ml/min/1.73 m 2 ) with a higher percentage (32%) of people with renal disease (eGFR 2560 mL/min), highest glycosilated hemoglobin (8.9%), and highest percentage of insulin use (62%) or sodiumglucose transporter-2 inhibitors (SGLT-2i) (15%) at baseline, thus identifying a more fragile population

Working with your provider for safe dosing Your provider prescribed a specific dose in milligrams

If your situation needs tailored advice, contact the RNA Law team